United States Biotechnology & Medical Research

SQZ Biotechnologies Co (SQZ)

Track

Track

Ticker: SQZ Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SQZ Biotechnologies Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Capasso Richard See Remarks Officer
Transaction date
Sale
Price
498.35
Quantity 58,977 +6.2%
Value US$2,796,330
1.3
Jensen Klavs F. Non-Executive Director
Transaction date
Purchase
Price
239.04
Quantity 96,032 -42.9%
Value US$2,458,954
2.7
SCHULMAN AMY W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
83.51
Quantity 59,576 -45.8%
Value US$3,273,551
2.7
SCHULMAN AMY W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.88
Quantity 1,850 +inf%
Value US$20,128
2.7
SCHULMAN AMY W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 233,654 +10.1%
Value US$3,738,464
2.7
SCHULMAN AMY W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 16,346 +10.1%
Value US$261,536
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-16 2022-08-15 S Sale
3.2
Capasso Richard

See Remarks

Officer
58,977 +6.2%
498.35
US$2,796,330 		58,977 +6.2% 498.35 US$2,796,330
2022-05-27 2022-05-25 B Purchase
1.3
Jensen Klavs F.
Non-Executive Director
96,032 -42.9%
239.04
US$2,458,954 		96,032 -42.9% 239.04 US$2,458,954
2021-12-15 2021-12-13 B Purchase
2.7
SCHULMAN AMY W
Non-Executive Director Large shareholder
59,576 -45.8%
83.51
US$3,273,551 		59,576 -45.8% 83.51 US$3,273,551
2021-12-15 2021-12-13 B Purchase
2.7
SCHULMAN AMY W
Non-Executive Director Large shareholder
1,850 +inf%
10.88
US$20,128 		1,850 +inf% 10.88 US$20,128
2020-11-05 2020-11-03 B Purchase
3.2
Temasek Holdings (Private) Ltd
Large shareholder
625,000 +33.1%
16.00
US$10,000,000 		625,000 +33.1% 16.00 US$10,000,000
2020-11-03 2020-11-03 B Purchase
2.7
SCHULMAN AMY W
Non-Executive Director Large shareholder
233,654 +10.1%
16.00
US$3,738,464 		233,654 +10.1% 16.00 US$3,738,464
2020-11-03 2020-11-03 B Purchase
2.7
SCHULMAN AMY W
Non-Executive Director Large shareholder
16,346 +10.1%
16.00
US$261,536 		16,346 +10.1% 16.00 US$261,536
2020-11-03 2020-11-03 B Purchase
1.8
Polaris Management Co. VII, L.L.C.
Large shareholder
233,654 +10.1%
16.00
US$3,738,464 		233,654 +10.1% 16.00 US$3,738,464
2020-11-03 2020-11-03 B Purchase
1.8
Polaris Management Co. VII, L.L.C.
Large shareholder
16,346 +10.1%
16.00
US$261,536 		16,346 +10.1% 16.00 US$261,536
2020-11-03 2020-11-03 B Purchase
3.8
Invus Public Equities, L.P.
Large shareholder
465,000 +40.7%
16.00
US$7,440,000 		465,000 +40.7% 16.00 US$7,440,000
2020-11-02 2020-10-30 B Purchase
2.9
AMERICAN INTERNATIONAL GROUP INC
Large shareholder
625,000 +inf%
16.00
US$10,000,000 		625,000 +inf% 16.00 US$10,000,000
Explore more

More insider trading research around SQZ Biotechnologies Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America